Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):302-310.
doi: 10.1093/ehjcvp/pvab048.